Navigation Links
Boston Scientific to Acquire Atritech
Date:1/19/2011

a of the heart known as the left atrial appendage.  If these clots dislodge and enter the bloodstream they may block circulation to the brain, resulting in a stroke.  The WATCHMAN device is designed to close the left atrial appendage, thereby preventing clots within the appendage from being dislodged into the circulation.  Atritech has completed PROTECT-AF, an 800-patient randomized clinical trial of its WATCHMAN device that demonstrated a 38 percent relative risk reduction for stroke, cardiovascular death and systemic embolism compared to long-term warfarin therapy.  Atritech is currently enrolling patients in the PREVAIL study, a confirmatory study designed to gain U.S. Food and Drug Administration approval.  The WATCHMAN device is CE Marked and was commercialized outside the United States in 2009.

"The acquisition of Atritech reinforces Boston Scientific's continued commitment to providing the broadest portfolio of less-invasive devices across the continuum of cardiovascular care," said Hank Kucheman, Executive Vice President and Group President, Cardiology, Rhythm and Vascular for Boston Scientific.  "The WATCHMAN device is implanted by both electrophysiologists and structural heart-focused interventional cardiologists.  We will leverage expertise from our Electrophysiology and Interventional Cardiology sales forces to drive commercialization of the WATCHMAN device.  Atritech will significantly strengthen our product offerings for patients with atrial fibrillation."  

"Both Atritech and Boston Scientific believe that the WATCHMAN device offers the best alternative to oral anticoagulation medication for patients who suffer from atrial fibrillation and are at high risk for stroke," said Jim Bullock, President and Chief Executive Officer of Atritech.  "We look forward to working with Boston Scientific to expand the left atrial appendage closure market and to bring this technology to more patients worl
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015 Research and ... of the  "2015 Strategies in the Global ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... of the orthopedics market, including forecasts for ... categories. , ,In addition, the report presents ...
(Date:5/27/2015)... Research and Markets ( ... the  "North America Mammography Market - Growth, ...  report to their offering.      ... detailed type of imaging that customs a ... mammography exam, called a mammogram, is used ...
(Date:5/27/2015)... 27, 2015 OpportunityAnalyzer: Sepsis - Opportunity Analysis ... suffer from a series of diverse complications arising from ... blood or tissues, which cause a rapidly progressing hyperactive ... rates near 50% depending on disease severity. The syndrome ... of the global marketplace, which for the purposes of ...
Breaking Medicine Technology:Global Orthopedics Market Strategies 2015 2North America Mammography Market - Growth, Trends And Forecasts (2014 - 2019) 2OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 2OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 3OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 4
... 2012   CANTEL MEDICAL CORP. (NYSE:CMN) announced today ... presenting at the Needham & Company, LLC  14th Annual ... AM ET on Wednesday, January 11, 2012 at The ... session immediately following the presentation. In addition, Mr. Krakauer ...
... 4, 2012 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), ... focused on cardiac and vascular surgery, announced today that ... position of Vice President, Research and Development; and David ... President, Market Development Surgical Adhesives and Starch Medical Relations.  ...
Cached Medicine Technology:CryoLife Enhances Management Team with Promotions 2CryoLife Enhances Management Team with Promotions 3CryoLife Enhances Management Team with Promotions 4CryoLife Enhances Management Team with Promotions 5
(Date:5/27/2015)... California (PRWEB) May 27, 2015 Western ... marked by a few historic firsts -- and one ... the Pasadena Civic Center marked the first time the ... the first time a Graduate College of Biomedical Sciences ... of the Pacific (COMP). , The university’s fifth and ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 “We are ... Schuller, MD, executive vice president and vice president of ... grant makes possible allows us to provide comprehensive care ... our community.” , SSCHC provides clinical care and behavioral ... 35,000 people in 2014, many of whom took advantage ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 While hair ... hair loss, a new pilot study conducted by a ... Surgery (ISHRS) has found hair follicle grafting can help ... research was partially funded by ISHRS, which offers research ... to hair restoration. , In the past decade, ...
(Date:5/27/2015)... 2015 NOVAtime Technology, Inc. ( ... solutions for enterprise organizations, announced today that SanMar ... automate its time, attendance and point tracking processes ... the United States. , Family-owned since 1971, ... 21 retail, private label, and mill brands. SanMar ...
(Date:5/27/2015)... ABILENE, Texas (PRWEB) May 27, 2015 ... addition of three FDA-approved dermal filler treatments in Abilene, ... designed to reduce the appearance of glabellar lines, better ... lines. Belotero Balance® is designed to treat smoker’s ... mouth to the chin, while Radiesse® improves the appearance ...
Breaking Medicine News(10 mins):Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 2Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 3Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 4Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 5Health News:Sixteenth Street Community Health Centers To Expand Primary Care and Behavioral Health Services Through $1 Million Grant From Aurora's Better Together Fund 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 3Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2
... The California Alliance for Inclusive Communities (CAIC) has recently ... 374. They join the majority of state and national ... is an advocacy group that works on behalf of ... ,Just as a new national AP/Ipsis poll ...
... new report released today by the Pharmaceutical Research and ... testing 277 medicines for two of the three leading ... and stroke. The medicines are currently in clinical trials ... (FDA). ,'Heart disease and stroke are still ...
... advent of a possible new blockbuster drug and greater ... drug addictions, global sales of smoking cessation and ... little over $1.1 billion in 2005 to more than ... Addiction Treatments: A World Market Analysis, a new study ...
... effects on cardiometabolic risk factors beyond those expected from ... may not be due to the drug itself, reports ... Therapeutics Bulletin (DTB). ,Advertisements for rimonabant ... that an estimated 50% of the effects on ...
... year the last day of May is celebrated as the ... World Health Organization to wag a warning finger at the ... This year the focus is on 100% smoke free ... to tobacco. There is also an effort to highlight the progress ...
... smokers today by declaring the site of the Beijing Olympics a ... Olympic venues and restaurants," The Telegraph quoted Zhang Jianshu, a city ... issue can raise has already been seen at the stadiums for ... by security guards to stop construction workers taking a cigarette break ...
Cached Medicine News:Health News:More Than 270 Medicines in Testing for Heart Disease and Stroke 2Health News:Anti-obesity Drugs Claimed Additional Benefits on cardiometabolic Risk Factors Questioned 2Health News:Stop Smoking, Start Living: World No Tobacco Day 2Health News:Stop Smoking, Start Living: World No Tobacco Day 3Health News:Stop Smoking, Start Living: World No Tobacco Day 4Health News:China Bans Smoking at Olympics 2
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
For the qualitative detection of luteinising Hormone (LH) in urine specimens...
For the qualitative detection of luteinising Hormone (LH) in urine specimens...
For the qualitative detection of group A Streptococcal antigen from throat swabs...
Medicine Products: